Madrigal Pharmaceuticals, Inc. (MDGL)
511.84
-4.90
(-0.95%)
USD |
NASDAQ |
Aug 24, 16:00
511.84
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals Price to Book Value : 22.57 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 22.79 |
| August 20, 2026 | 22.89 |
| August 19, 2026 | 23.82 |
| August 18, 2026 | 23.12 |
| August 17, 2026 | 23.14 |
| August 14, 2026 | 22.38 |
| August 13, 2026 | 22.37 |
| August 12, 2026 | 23.64 |
| August 11, 2026 | 23.60 |
| August 10, 2026 | 22.72 |
| August 07, 2026 | 22.49 |
| August 06, 2026 | 22.50 |
| August 05, 2026 | 22.67 |
| August 04, 2026 | 22.38 |
| August 03, 2026 | 21.25 |
| July 31, 2026 | 20.61 |
| July 30, 2026 | 21.74 |
| July 29, 2026 | 24.12 |
| July 28, 2026 | 23.76 |
| July 27, 2026 | 24.31 |
| July 24, 2026 | 24.01 |
| July 23, 2026 | 23.96 |
| July 22, 2026 | 23.71 |
| July 21, 2026 | 24.11 |
| July 20, 2026 | 23.62 |
| Date | Value |
|---|---|
| July 17, 2026 | 24.41 |
| July 16, 2026 | 24.06 |
| July 15, 2026 | 24.26 |
| July 14, 2026 | 23.67 |
| July 13, 2026 | 23.41 |
| July 10, 2026 | 23.67 |
| July 09, 2026 | 24.69 |
| July 08, 2026 | 24.93 |
| July 07, 2026 | 24.05 |
| July 06, 2026 | 23.35 |
| July 02, 2026 | 23.29 |
| July 01, 2026 | 22.68 |
| June 30, 2026 | 23.68 |
| June 29, 2026 | 22.36 |
| June 26, 2026 | 21.74 |
| June 25, 2026 | 21.78 |
| June 24, 2026 | 21.61 |
| June 23, 2026 | 21.77 |
| June 22, 2026 | 21.75 |
| June 18, 2026 | 21.44 |
| June 17, 2026 | 21.19 |
| June 16, 2026 | 21.25 |
| June 15, 2026 | 21.19 |
| June 12, 2026 | 20.38 |
| June 11, 2026 | 20.11 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Insmed, Inc. | 35.74 |
| PTC Therapeutics, Inc. | -- |
| Protagonist Therapeutics, Inc. | 11.89 |
| Exelixis, Inc. | 7.366 |
| Karyopharm Therapeutics, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 10.31 |
| PEG Ratio | -139.45 |
| Price | 511.84 |
| Earnings Yield | -2.52% |
| Market Cap | 11.82B |
| PEGY Ratio | -139.45 |